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Abstract
 
Proper lymph node (LN) development requires tumor necrosis factor–related activation-
induced cytokine (TRANCE) expression. Here we demonstrate that the defective LN devel-
opment in TRANCE
 
2
 
/
 
2
 
 mice correlates with a significant reduction in lymphotoxin
(LT)
 
ab
 
1
 
a
 
4
 
b
 
7
 
1
 
CD45
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells and their failure to form clusters in rudimentary me-
senteric LNs. Transgenic TRANCE overexpression in TRANCE
 
2
 
/
 
2
 
 mice results in selective
restoration of this cell population into clusters, and results in full LN development. Transgenic
TRANCE-mediated restoration of LN development requires LT
 
ab
 
 expression on CD45
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells, as LNs could not be induced in LT
 
a
 
2
 
/
 
2
 
 mice. LT
 
a
 
2
 
/
 
2
 
 mice also showed
defects in the fate of CD45
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells similar to TRANCE
 
2
 
/
 
2
 
 mice. Thus, we pro-
 
pose that both TRANCE and LT
 
ab
 
 regulate the colonization and cluster formation by CD45
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells in developing LNs, the degree of which appears to correlate with the state of
LN organogenesis.
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Introduction
 
LNs are highly organized structures found in higher ver-
tebrates, which concentrate antigens, antigen-presenting
cells, and antigen-specific lymphocytes into physical prox-
imity to provide microenvironments for optimal immune
responses. In addition, within this highly organized struc-
ture, antigen-specific T or B lymphocytes are activated and
differentiate to become effector cells. Therefore, LNs are
believed to be critical secondary lymphoid organs for the
initiation of immune responses.
LN development is a continuous process, but five dis-
tinct stages of LN organogenesis can be proposed based on
histological studies (1–4).
 
Stage I.
 
The lymphatic system develops by the forma-
tion of lymphatic sacs that originate as endothelial budding
from the veins (starting as early as embryonic day [E]10.5 of
the mouse). Prox1, a homologue of 
 
Drosophila
 
 
 
prospero
 
, was
recently shown to be essential for budding of endothelial
cells from veins, the deficiency of which resulted in com-
plete arrest of the lymphatic system and subsequent early
lethality (5).
 
Stage II.
 
Lymphatic vessels develop by endothelial
sprouting from those lymph sacs.
 
Stage III.
 
The anlagen of LNs are formed by invagina-
tion of mesenchymal connective tissues into the lumen of
growing lymph sacs. The resulting network of lymph
channels forms the lymphatic plexus, which can give rise to
LNs. Mesenchymal connective tissue invaginations are thus
the anlage of LN parenchyma, which contain reticular
cells, fibroblasts, some leukocytes, capillaries, and vascular
loops. Therefore, primordial LNs are primarily cellular re-
ticula surrounded by endothelial cells from lymph channels,
which will form the subcapsular sinus. The blood supply of
the fetal LNs is already present at this stage, via vessels that
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run through the stalk of the connective tissue invagination.
It is within the LN anlage that the specialized endothelial
cells form, supporting leukocyte traffic from the blood-
stream into the underlying LN parenchyma.
 
Stage IV.
 
The cellular density and leukocyte content in
the LN anlage increase and the subcapsular sinus is formed.
It is probably during this stage of LN formation that the
majority of hematopoietic lineage precursor cells colonize
the nodal parenchyme.
 
Stage V.
 
The anlage of LNs continues to expand and
form capsules. The cellular density and leukocyte content
continue to increase, and mature lymphocytes migrate into
the developing LNs and establish proper cellular microar-
chitecture.
Recent genetic experiments have revealed that members
of the TNF/TNFR family are critically involved in LN or-
ganogenesis and in the maintenance of LN and splenic mi-
croarchitecture (6). Inactivation of the lymphotoxin (LT)
 
1
 
pathway in mice resulted in the absence of LNs and Peyer’s
patches (PPs), indicating the pivotal role of membrane LT
(LT
 
ab
 
) and its receptor (LT-
 
b
 
R) for LN genesis (7–14).
Histological analysis of LN regions in mutant adult mice
showed no LN-like structures but retained intact lymphatic
vasculature of vein, arteria, and lymphatic vessel (14), sug-
gesting that defects in these mice do not lie in the forma-
tion of lymphatic vasculature (stage II). In addition to its
role during the LN genesis, the LT
 
ab
 
/LT-
 
b
 
R system is
also critical for the maintenance of microarchitecture of
adult spleens, as antagonism of LT
 
ab
 
 in adult mice caused
disruptions in splenic T/B organization, marginal zone in-
tegrity, and follicular dendritic cell networks (11, 13–16).
The TRANCE/TRANCE-R pathway provided a sec-
ond example of TNF/TNFR family members critically
involved in LN development. Inactivation of murine
TRANCE or TRANCE-R resulted in the absence of all
peripheral LNs (PLNs) and mesenteric LNs (MLNs) (17,
18). However, in contrast to the LT
 
ab
 
/LT-
 
b
 
R system,
the TRANCE/TRANCE-R system was not essential for
the genesis of PPs. In addition, it was reported that disrup-
tion of the TRANCE/TRANCE-R system did not affect
splenic microarchitecture (17).
Despite accumulating data implicating various TNF/
TNFR family members (6), and also their signal transduc-
ers such as TNFR-associated factor (TRAF)6, nuclear fac-
tor (NF)-
 
k
 
B–inducing kinase (NIK), or RelB, in the regu-
lation of LN development (19–23), little is known about
how these molecules regulate LN genesis during develop-
ment. Hence, we generated TRANCE
 
2
 
/
 
2
 
 mice to further
dissect the role of TRANCE during LN development and
also to study the potential relationship between the
TRANCE/TRANCE-R and the LT/LT-
 
b
 
R systems in
the regulation of LN genesis. Here we show that arrested
 
LN development in TRANCE
 
2
 
/
 
2
 
 mice is due to the im-
paired colonization and subsequent cluster formation of he-
matolymphoid precursor cells within the developing LN
anlage. In particular, we show that the degree of coloniza-
tion and cluster formation of 
 
a
 
4
 
b
 
7
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells in the
primordial LN structures correlated with the presence of
LNs in adults. Similar to TRANCE
 
2
 
/
 
2
 
 mice, LT
 
a
 
2
 
/
 
2
 
mice also showed impaired colonization and cluster forma-
tion of 
 
a
 
4
 
b
 
7
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells in the LN anlage. These re-
sults thus suggest that both TRANCE and LT ligands reg-
ulate the LN genesis by controlling the colonization and
cluster formation of 
 
a
 
4
 
b
 
7
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells during LN de-
velopment. As the defects in the TRANCE/TRANCE-R
or LT/LT-
 
b
 
R system did not affect the initiation of colo-
nization by 
 
a
 
4
 
b
 
7
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells, the results suggest that
neither TRANCE nor LT are intrinsically required for the
initiation of the formation of LN anlage, but are required
for further development during stage III of the LN anlage.
 
Materials and Methods
 
Generation of TRANCE-deficient or Transgenic Mice.
 
To gen-
erate TRANCE
 
2
 
/
 
2
 
 mice, a 129SvJ mouse 
 
l
 
 FIXII genomic li-
brary (Stratagene) was screened using the full-length murine
TRANCE cDNA probe. An 
 
z
 
42-kb contig was assembled from
overlapping clones comprising exons 2–5, which allowed con-
struction of the replacement vector, pPNT-TRANCE-RV1.2,
as follows: a 1.8-kb BamHI-KpnI genomic short arm subcloned
into the pSL301 vector (Invitrogen) was released as an EcoRI-
KpnI fragment for antisense insertion 5
 
9
 
 to PGKneopA of the
pPNT vector. An 8.2-kb SspI-SspI genomic long arm subcloned
into the HincII site of pBS KSII
 
1
 
 (Stratagene) was released as an
XhoI-NotI fragment for 3
 
9
 
 antisense ligation next to PGKneopA.
E14.1 embryonic stem cells (5 
 
3
 
 10
 
7
 
) were electroporated with
NotI-linearized pPNT-TRANCE-RV1.2 and transformants
were selected after 7–8 d in 180 
 
m
 
g/ml active geneticin (GIBCO
BRL) plus 2 
 
m
 
M gancyclovir (Roche), the latter yielding about
threefold enrichment. Genomic DNAs isolated from individual
colonies were EcoRI digested and Southern blot hybridized with
a 5
 
9
 
 flanking probe (0.95-kb EcoRI-BamHI fragment immedi-
ately adjacent to the short arm). Two targeted embryonic stem
cell clones (TR-73 and TR-96) carrying single integration
events, as shown by Southern probing with a 1.6-kb NotI-KpnI
PGKNeopA fragment, were microinjected into C57BL/6 blasto-
cysts to produce germline chimeras.
For TRANCE.TG mice, we have generated several transgenic
mouse lines overexpressing TRANCE under the control of the
murine CD4 enhancer/promoter lacking CD4 silencer sequences
and thus driving the expression of transgene in CD4 as well as in
CD8 cells (24; Wong, B.R, and Y. Choi, unpublished data). Three
independent transgenic lines were obtained. Two lines (TRANCE.-
TG-3, TRANCE.TG-40) expressed transgenic TRANCE only
on T cells, but one line, TRANCE.TG-1, expressed transgenic
TRANCE in both B and T cells as shown in this study. None of
the mice expressed detectable levels of transgenic TRANCE on
CD45
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells in developing LNs. These results sug-
gest that promoter/enhancer elements for CD4 expression in
CD45
 
1
 
CD4
 
1
 
CD3
 
2
 
 cells and T cells must be different.
 
PCR Analyses.
 
To genotype the mice, genomic PCR was
performed on phenol/chloroform-extracted tail biopsy DNA or
 
1
 
Abbreviations used in this paper: 
 
CLN, cervical LN; GC, germinal center;
HPRT, 5
 
9
 
-hypoxanthine ribosyltransferase; LT, lymphotoxin; MAd-
CAM, mucosal addressin cell adhesion molecule; MLN, mesenteric LN;
PLN, peripheral LN; PP, Peyer’s patch; rMLN; rudiments of MLN;
TRANCE, TNF-related activation-induced cytokine; WT, wild-type. 
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fetal liver genomic DNA in a 50-
 
ml PCR reaction (10 mM Tris-
HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 200 mM dNTPs,
and 0.5 U Taq polymerase; Sigma-Aldrich). Primer composition
and concentration, together with the product size and PCR con-
ditions used, were the following: 59-TRANCE (0.5 mM), 59-
CCAAGTAGTGGATTCTAAATCCTG-39; 39WT (0.2 mM),
59-GGTTGGACACCTGAATGCTAATTTC-39 (345 bp); and
39 NeoRec (0.2 mM), 59-ATTCGCAGCGCATCGCCTTC-
TATCG-39 (575 bp); 948C, 5 min; 30 cycles (948C, 30 s; 588C,
45 s, 728C, 1 min); and 728C, 7 min.
Semiquantitative reverse transcription PCR was performed
on first-strand synthesized thymocyte cDNA as described (25).
Primers used were the following: 59-hypoxanthine ribosyltrans-
ferase (HPRT), 59-GTAATGATCAGTCAACGGGGGAC-39;
39-HPRT, 59-CCAGCAAGCTTGCAACCTTAACCA-39;
59-TRANCE-R, 59-CCCGAATTCTACTACAGGAAGGGA-
GGGAAG-39; 39-TRANCE-R, 59-CCTGCTGGATTAGGA-
GCAGTG-39; 59-TRANCE, 59-CCTGAGACTCCATGAAA-
CGC-39; and 39-TRANCE, 59-TAACCCTTAGTTTTCC-
GTTGC-39.
LN Enumeration. Video-captured binocular stereomicro-
scope images (310 magnification) were obtained during inspec-
tion under a Leica M16 dissection microscope. In addition, some
mice were injected subcutaneously with Evan’s blue dye (1:10
dilution) 3 h before killing.
Abs and Flow Cytometry. The following reagents and Abs
were used for staining: TRANCE-R-hIgG1 (TR-Fc [25]);
1E6.66 (rat anti–TRANCE-R mAb) GK5.1 (anti-CD4); RM4-5
(anti-CD4); 145-2C11 (anti-CD3); 53-6.7 (anti-CD8); 104
(anti-CD45.2); H57-597 (anti-TCR); RA3-6B2 (anti-B220);
R6-60.2 (anti-IgM); 11-26C.2a (anti-IgD); HL-3 (anti-CD11c);
M1/70 (anti-CD11b); PC61 (anti-CD25); IM7 (anti-CD44);
S7 (anti-CD43); mLT-bR-hIgG1 (11); AF.H6 (agonistic anti–
mLT-bR mAb [13]; DATK-32 (anti–LPAM-1); MECA-367
(anti–mucosal addressin cell adhesion molecule [MAdCAM]-1);
and 3D6.112 (antisialoadhesin; Serotec). Samples were erythro-
cyte lysed and pretreated with anti-CD16/32 FcR mAb 2.4G2
(1:50 dilution) before undergoing four-color fluorometry using
a FACSCalibur™ with argon and helium–neon lasers (Becton
Dickinson).
Immunofluorescence Analysis. For immunofluorescence analyses
on frozen sections, mouse organs were harvested, frozen, sec-
tioned, and, after being preblocked with 2.4G2 in PBS, stained as
described (11, 12, 26). In brief, cryostat sections (5 mm thick)
were allowed to air dry and fixed in acetone. The sections were
incubated with primary Abs for 45 min, rinsed in PBS, and incu-
bated with secondary Abs for 30 min, rinsed with PBS, and cov-
erslipped using antifading mounting media. The primary Abs used
were Alexa-488–conjugated anti-CD4 and biotin-labeled anti–
MAdCAM-1. For whole-mount immunofluorescence analysis,
freshly isolated day 0 MLNs or rudiments of MLNs (rMLNs)
were stained with FITC-conjugated anti-CD4 Ab and PE-labeled
anti–MAdCAM-1. For this, the whole MLNs or rMLNs were
incubated with Abs at 48C for 3–4 h, washed three times, and vi-
sual data were acquired with an Axioplan 2 fluorescent micro-
scope (ZEISS) equipped with a SensiCam CCD camera (Cooke
Corporation) using SlideBook software (Intelligent Imaging Co.).
Germinal Center Formation. 6-wk-old mice were immunized
intraperitoneally with 50 mg of (4-hydroxy-3-nitrophenyl-
acetyl)-KLH (NP12-KLH; Biosearch Technologies). Splenic ger-
minal center (GC) formation was examined 10 d after immuniza-
tion in cryosections with peanut agglutinin (PNA)-biotin/
streptavidin–PE and IgM-FITC as described (11, 12).
Results
Inactivation of the Murine TRANCE Gene: A Gene Dosage
Effect on the Level of TRANCE Expression. TRANCE2/2
mice were described as having a defect in LN organogene-
sis but not in PP development or maintenance of splenic
architecture (17). To further study the role of TRANCE in
LN genesis, we have generated TRANCE2/2 mice by ho-
mologous recombination, in which nucelotides 699–1089
of exon 5 (amino acids 185–316) plus the additional 1123-
bp 39 untranslated region have been deleted (data not
shown). The overall phenotype of our TRANCE2/2 mice
was essentially similar to that described (17) such that
TRANCE2/2 mice failed to develop PLNs and MLNs (see
below) and osteoclasts (data not shown). Of note, however,
we showed here that TRANCE1/2 mice displayed inter-
mediate levels of TRANCE expression (Fig. 1), indicating
a gene dosage effect.
Figure 1. Generation of TRANCE2/2 mice: a gene
dosage effect on TRANCE expression. (A) Reverse tran-
scription PCR analysis of thymocytes or activated CD81 T
cells from WT, TRANCE1/2, and TRANCE2/2 mice.
TRANCE-R mRNA expression was also examined and
HPRT served as an internal control. (B) Flow cytometric
analysis of activated CD81 T cells from WT, TRANCE1/2,
and TRANCE2/2 mice. Cells were stained with hIgG1
(gray lines) or TRANCE-R-IgG1 (thick lines) followed by
PE-coupled goat anti–human IgG1.1470 Lymph Node Organogenic Defects in TRANCE-deficient Mice
Altered Splenic B Cell Follicles in TRANCE2/2 Mice.
There were no major defects in overall splenic architecture
in TRANCE2/2 mice, as reported (17). However, immu-
nofluorescence analyses of spleen sections revealed altered
splenic microarchitecture in .70% of TRANCE2/2 mice.
Although lymphocytes segregated into discrete T and B
cell zones, there were defects in B cell follicle formation
and marginal zone integrity. The degree of these defects in
TRANCE2/2 mice, however, varied considerably even in
the same mice: we observed T cell–rich periarteriolar lym-
phoid sheath with only sparse B cell rings but no follicles,
with B cell rings but no follicles, or with apparently normal
B cell follicles (Fig. 2 A). To assess marginal zone integrity,
we stained spleen sections with Ab specific for sialoadhesin,
a marker of marginal zone macrophages. Wild-type (WT)
and TRANCE1/2 mice revealed a tight, bright ring of
staining which encompassed the entire marginal zone, bro-
ken only by bridging channels (data not shown). In con-
trast, most TRANCE2/2 mice had variable staining which
was repeatedly interrupted and diffuse. About 75% of
TRANCE2/2 mice manifested a defect in marginal zone
integrity; the remaining z25% appeared relatively normal.
TRANCE2/2 mice, which had relatively normal marginal
zone staining, also had relatively intact B cell follicles (data
not shown). Despite these defects, upon immunization
with the T cell–dependent antigen nitrophenol-haptenated
KLH, GCs were formed in spleens of TRANCE2/2 mice
that were comparable to those in WT mice (Fig. 2 B).
These results suggest that TRANCE contributes to but is
not essential for the proper formation of B cell follicles in
spleen.
Absence of LNs in TRANCE2/2 Mice. TRANCE2/2 mice
showed defective LN development (Fig. 3 A) but normal
PPs (data not shown), consistent with a previous report
(17). Although most TRANCE2/2 mice failed to develop
any PLNs or MLNs, we have occasionally observed that
cervical LNs (CLNs) develop in TRANCE2/2 mice (z30%
of TRANCE2/2 mice examined contained one of the
CLNs; Fig. 3 B). Such CLNs appeared to be bona fide LNs
with T and B cells segregated into discrete zones (Fig. 3 B).
However, B cells failed to form follicles in those CLNs,
similar to the defect observed in the spleens of z70% of
TRANCE2/2 mice.
We also noted that a small number of the TRANCE1/2
mice, having an intermediate level of TRANCE expres-
sion, failed to develop some PLNs (z7% of TRANCE1/2
mice lacked one inguinal LN and z3% of TRANCE1/2
mice lacked one iliac LN; Fig. 3 C). However, none of the
TRANCE1/2 mice showed any abnormality in the forma-
tion of MLNs. Thus, these results indicate a haploinsuffi-
ciency effect of TRANCE on the formation of some
PLNs.
Figure 2. Altered primary B cell follicles
but apparently normal formation of GCs in
spleen of TRANCE2/2 mice. (A) Immu-
nofluorescence photomicrographs of repre-
sentative spleen sections from WT,
TRANCE1/2, and TRANCE2/2 mice.
Spleens were dissected from 3–4-wk-old
mice and stained with anti-B220 (FITC)
and anti-CD4 (PE). (B) Representative im-
munofluorescence photomicrographs of
spleen sections prepared 10 d after immuni-
zation of mice with 50 mg NP12-KLH ad-
sorbed to alum. Immunofluorescence mi-
croscopy was performed to detect formation
of GCs (PNA-biotin/streptavidin–PE and
anti-IgM–FITC).1471 Kim et al.
Expression of TRANCE and TRANCE-R in Cells within
Developing LNs. As described above, the most dramatic
effect of TRANCE gene deletion is on the development of
PLNs and MLNs. As the formation of LN structure is reg-
ulated during the early development of mice, we examined
TRANCE and TRANCE-R expression in developing
LNs. For this study, we isolated MLNs from new-born
WT mice (day 0 MLNs).
At the time of birth, MLNs contain various types of he-
matolymphoid cells. In particular, day 0 MLNs are colo-
nized by CD451CD41CD32 cells, which express surface
LTab (Fig. 4), and other gene products (e.g., RelB, IL-
2Rgc chain, or BLR-1 [27]), which have been shown to
play important roles in LN development (22, 23, 28, 29).
We failed to detect surface TRANCE expression in freshly
isolated cells from day 0 MLNs by FACS® analysis using
TRANCE-R-IgG1 fusion protein (data not shown). How-
ever, upon a brief culture of day 0 MLN cells in medium,
we could detect surface TRANCE expression specifically
on CD451CD41CD32 cells (Fig. 4). The length of culture
period between 1 and 2 h did not affect the level of
TRANCE expression (data not shown), suggesting that
Figure 3. TRANCE is essential for
proper development of PLNs. (A)
Evan’s blue dye was injected into all
footpads and images of the PLNs were
obtained. Shown are MLNs, iliac, and
sacral (Sac.) LNs. Apart from the
CLNs (see panel B), 100% of
TRANCE2/2 mice lacked all PLNs
and MLNs. (B) The presence of CLNs
in TRANCE2/2 mice. A represen-
tative image of CLNs found in
TRANCE2/2 mice (left). A represen-
tative immunofluorescence analysis of
CLNs obtained from TRANCE2/2
with anti-CD4–PE and anti-B220–
FITC (right). (C) Haploinsufficiency
effect of TRANCE on the develop-
ment of PLNs. A representative image
of TRANCE1/2 mice lacking one of
the inguinal (Ing.) LNs.
Figure 4. CD451CD41CD32
cells in day 0 MLNs express
TRANCE and TRANCE-R.
Cells obtained from WT day 0
MLNs were stained with anti-
CD4, anti-CD45, and TRANCE-
R-IgG1 (for TRANCE), 1E6.66
(for anti–TRANCE-R), LT-bR-
IgG1 (for surface LTab), or AF.H6
(for anti–LT-bR) (thick lines).
Cells were isolated by mechani-
cal disruption of day 0 MLNs.
Similar results were also obtained
when cells were isolated by col-
lagenase digestion of day 0 MLNs
(data not shown). For detection
of surface TRANCE, cells ob-
tained from day 0 MLNs were
cultured in medium for 1–2 h before staining with TRANCE-R-IgG1. Gray histograms are negative controls. For TRANCE-R-IgG1 and LT-bR-
IgG1, incubation with human IgG1 was performed as a negative control. For anti–TRANCE-R mAb (1E6.6) and anti–LT-bR Ab (AF.H6), rat IgG and
hamster anti-KLH (Ha/48) were used as negative controls, respectively.1472 Lymph Node Organogenic Defects in TRANCE-deficient Mice
surface TRANCE might have been shed due to its con-
tinuous interaction with the receptor in developing MLNs.
The restricted expression of TRANCE on CD451CD41
CD32 cells was similar to that of surface LTab (Fig. 4).
We have also examined the expression of surface
TRANCE-R by FACS® analysis using anti–TRANCE-R
mAb (1E6.66) on cells from day 0 MLNs. Unlike
TRANCE, TRANCE-R was readily detected in freshly
isolated CD451CD41CD32 cells as well as in some
CD451CD42 cells (Fig. 4). TRANCE-R1CD451CD42
cells were also shown to express B220, CD19, and surface
IgM, indicating that they are B cells (data not shown).
However, TRANCE-R was not detected on CD452 cells.
In contrast to the expression of TRANCE-R on cells of
hematolymphoid lineages, LT-bR expression was detected
only on a subpopulation of CD452 stromal or endothelial
cells found in day 0 MLNs (Fig. 4).
Thus, these results indicate that, although both TRANCE
and LTab are expressed on the same population of cells
(i.e., CD451CD41CD32) colonizing the developing LNs,
TRANCE-R and LT-bR are expressed on a discrete pop-
ulation of cells, suggesting that TRANCE and LTab may
affect different cell types within developing LNs.
The colonization of developing LNs by CD451CD41
CD32 cells has been of particular interest, as these cells ex-
press surface LTab and other gene products that are essen-
tial for LN genesis (27). As TRANCE, similar to LTab, is
also expressed specifically on CD451CD41CD32 cells in
developing LNs (day 0 MLNs), we speculated that the fate
of those cells in developing LNs might be regulated by
TRANCE or LTab during LN development. To test this
hypothesis, we have collected day 0 MLNs from WT mice
and rMLNs, which is the area where MLNs should have
developed, from newborn TRANCE2/2 and LTa2/2 mice
(Fig. 5 A). Day 0 rMLNs from TRANCE2/2 (Fig. 5 A)
and LTa2/2 mice (data not shown) were connected to the
lymphatic vessels from the small intestines and filled with
milky white fluid (probably chyle) at the time of killing, in-
dicating that TRANCE2/2 mice have developed lym-
phatic vessels (stage II), as do LTa2/2 mice.
In WT day 0 MLNs, z50% of CD451 cells are CD41
CD32 cells, all of which express a4b7 integrin (measured
by FACS® analysis using anti-a4b7 mAb, LPAM-1; Fig. 5,
B and C), which is the ligand for MAdCAM-1, a dominant
addressin on high endothelial venules in developing MLNs
(26, 27, 30). When the topology of these CD451CD41
Figure 5. Reduction of colonization by CD451CD41CD32 cells and their failure to form clusters in TRANCE2/2 or LTa2/2 mice. (A) A represen-
tative image of MLNs from newborn WT mice and of rMLNs found in newborn TRANCE2/2 mice. Dotted circles indicate MLNs or rMLNs isolated.
Similar rMLNs were observed in newborn LTa2/2 mice (data not shown). Lymphatic vessels are white, presumably due to the chyle being drained from
intestines. (B) A representative flow cytometric analysis of cells taken from day 0 MLNs from WT mice or rMLNs from TRANCE2/2 and LTa2/2
mice. (C) The percentage of CD451 cells showing the CD41CD32 phenotype in day 0 MLNs from WT mice or rMLNs from TRANCE2/2 and
LTa2/2 mice. (D) Representative immunofluorescence analysis of frozen sections obtained from day 0 intestines from WT or TRANCE2/2 mice. Sec-
tions were stained with anti-CD4–Alexa-488 and anti–MAdCAM-1–PE.1473 Kim et al.
CD32 cells in the developing LNs was examined by stain-
ing the freshly isolated whole day 0 MLNs, we found that
these cells were organized into compact clusters in discrete
regions of day 0 MLNs (Fig. 6). Moreover, CD451CD41
CD32 cells were identified as clusters colocalizing with
MAdCAM-11 endothelial venules (Fig. 6).
In day 0 rMLNs of TRANCE2/2 mice, the overall per-
centage of CD451 cells was significantly reduced (about a
fourfold reduction) compared with that in day 0 MLNs of
WT mice (data not shown). In addition to the overall re-
duction of CD451 cells, there was a selective decrease in
the percentage of CD451CD41CD32 cells in day 0
rMLNs from TRANCE2/2 mice (Fig. 5, B and C) such
that only z10% of CD451 cells were CD451CD41CD32
cells. Although reduced in numbers, the CD451CD41
CD32 cells found in day 0 rMLNs from TRANCE2/2
mice still expressed a4b7 integrin at levels comparable to
those of WT cells (Fig. 5, B and C). In addition to the re-
duced number of CD451CD41CD32 cells in day 0 rMLNs
observed by FACS® analysis, immunofluorescence analysis
showed that the few CD451CD41CD32 cells that were
present were found scattered over the entire rMLNs, in
contrast to cluster-forming CD451CD41CD32 cells in
WT day 0 MLNs (Fig. 6). In addition, the network of
MAdCAM-11 endothelial venules, which were observed
in day 0 MLNs from WT mice, was dramatically underde-
veloped in TRANCE2/2 mice (Fig. 6).
For comparison, we also examined rMLNs from new-
born LTa2/2 mice, which also fail to develop LNs. Similar
to TRANCE2/2 mice, LTa2/2 mice showed a reduction
in the percentage of CD451 cells in day 0 rMLNs (data not
shown). In addition, a significant reduction (about twofold)
in the percentage of CD41CD32 cells within the CD451
population was observed in day 0 rMLNs of LTa2/2 mice
(Fig. 5, B and C). The remaining cells expressed normal
levels of a4b7 integrin (Fig. 5, B and C). Compared with
day 0 rMLNs from TRANCE2/2 mice, more CD451
CD41CD32 cells were observed in LTa2/2 day 0 rMLNs
(Fig. 5, B and C). However, as in TRANCE2/2 mice, the
CD451CD41CD32 cells were scattered throughout the
rMLNs (Fig. 6). The network of MAdCAM-11 endothe-
lial venules as well as their thickness was also dramatically
diminished compared with day 0 MLNs from WT mice
(Fig. 6).
In contrast to developing LNs, day 0 intestines from WT
mice and TRANCE2/2 mice contained a comparable per-
centage of CD41CD32 cells within the CD451 population
(data not shown), which are identified as clusters (Fig. 5 D).
Day 0 intestines from LTa2/2 mice were previously shown
to contain CD41CD32 cells, but failed to form clusters (31).
Taken together, these results indicate that the TNF fam-
ily members TRANCE and LTab regulate the coloniza-
tion of developing LNs by hematolymphoid lineage cells,
in particular by CD451CD41CD32 cells, either by affect-
ing their migration into the developing LNs or by affecting
their persistence/differentiation within the LN anlage.
Moreover, the ability of CD451CD41CD32 cells to form
clusters in developing LNs is also regulated by TRANCE
and LTab.
Ectopic Expression of TRANCE Transgene Restores LNs and
CD451CD41CD32 Cells to TRANCE2/2 Mice. To de-
termine whether ectopic expression of TRANCE can re-
store LN development in TRANCE2/2 mice, we crossed
TRANCE2/2 mice to TRANCE.TG-1, a transgenic
mouse line overexpressing TRANCE in T and B cells (see
Materials and Methods). As reported previously, FACS®
analysis of freshly isolated resting mature T or B cells using
TRANCE-R-IgG1 fusion protein does not reveal any sig-
nificant surface TRANCE expression in WT mice (25).
However, transgenic (or overexpressed) TRANCE was
readily detected on most of the freshly isolated mature T or
B cells from TRANCE.TG-1 mice (data not shown).
In newborn TRANCE.TG-1 mice, transgenic TRANCE
was overexpressed in CD41CD81 thymocytes (Fig. 7 A).
When freshly isolated day 0 MLN cells from TRANCE.
TG-1 mice were analyzed, a large number of B2201
Figure 6. Both TRANCE and LT-a
are required for cluster formation by
CD451CD41CD32 cells and for the forma-
tion of MAdCAM-11 endothelial cell net-
work within developing LNs. Representa-
tive images taken from whole mount
staining of freshly isolated MLNs from new-
born WT or TRANCE(2/2,Tg) mice, and
rMLNs from TRANCE2/2 or LTa2/2
mice. The whole MLNs or rMLNs were
stained with anti-CD4–FITC and anti–
MAdCAM-1–PE.1474 Lymph Node Organogenic Defects in TRANCE-deficient Mice
CD191 cells overexpressing TRANCE, but not CD31
cells, were observed (Fig. 7 A). Furthermore, we failed to
detect overexpressed TRANCE on freshly isolated CD451
CD41CD32 cells in day 0 MLNs from TRANCE. TG-1
mice. Although overexpressed TRANCE in day 0 MLNs
was detected only in B cells, the cell lineage delivering the
TRANCE-dependent signal for LN development in the
transgenic mice is not known.
Although transgenic TRANCE was not detected on
CD451CD41CD32 cells in developing MLNs, there was a
significant restoration of all PLNs when adult TRANCE2/2
mice carrying the TRANCE transgene, TRANCE(2/2,Tg),
Figure 7. Ectopic expression of TRANCE restores LN development in TRANCE2/2 mice. (A) Transgenic TRANCE is overexpressed in T and B
cells, but not in CD41CD32 cells found in day 0 MLNs. Freshly isolated cells were incubated with the indicated Abs and examined by FACS® analysis.
(B) Representative images of PLNs (Iliac) and MLNs observed in TRANCE(2/2,Tg) mice. 4 h after injection of Evan’s blue dye, LNs were imaged. Note
that one of the two iliac LNs and sacral LNs were still missing in the TRANCE(2/2,Tg) mouse shown here. In addition, MLNs in these mice were smaller
than those in WT mice. (C) Representative immunofluorescence analysis of LNs from WT, TRANCE(1/1,Tg), and TRANCE(2/2,Tg) mice. Sections
were stained with anti-CD4–PE and anti-B220–FITC. Note that the righthand image in TRANCE(2/2,Tg) shows disrupted primary B cell follicle. (D)
The percentage of CD451 cells showing the CD41CD32 phenotype in day 0 MLNs from TRANCE(1/1,Tg) and TRANCE(2/2,Tg) mice. *For compar-
ison, the percentages of CD451 cells showing the CD41CD32 phenotype in day 0 MLNs from WT or rMLNs from TRANCE2/2 mice are included,
which were taken from Fig. 5 C. (E) The percentage of LNs restored in TRANCE(2/2,Tg) mice. *Although all of the TRANCE(2/2,Tg) mice contained
MLNs, the number of MLNs averaged two, compared with four to six MLNs found in WT mice. Mand., mandibular; Super., superficial; Cerv., cervi-
cal; Axi., axial; Brach., brachial; Mesen., mesentery; Ingui., inguinal; Lumb., lumbar; Sac, sacral; Pop., popliteal.1475 Kim et al.
were analyzed (Fig. 7, B and E). In all cases, TRANCE(2/2,Tg)
mice developed MLNs, though they were smaller than
MLNs in WT mice. Moreover, immunofluorescence anal-
ysis of these restored LNs revealed that they retained almost
normal cellular architecture, although the formation of B
cell follicles was somewhat defective (Fig. 7 C).
As we have shown above that day 0 rMLNs from
TRANCE2/2 mice contained reduced numbers of
CD451 cells and were not colonized by cluster-forming
CD451CD41CD32 cells, we also examined whether ec-
topic expression of TRANCE affected the fate of hema-
tolymphoid lineage cells in the developing MLNs of
TRANCE(2/2,Tg) mice. Although TRANCE(2/2,Tg) mice
developed MLNs, day 0 MLNs from these mice were still
significantly smaller and showed lower representation of
CD451 cells than those of WT or TRANCE.TG-1 litter-
mates such that the percentage of CD451 cells from day 0
MLN of TRANCE(2/2,Tg) mice was statistically not differ-
ent from that of TRANCE2/2 mice (data not shown).
However, day 0 MLNs of TRANCE(2/2,Tg) mice con-
tained a significantly higher percentage of CD41CD32 cells
within the CD451 population than day 0 rMLNs of
TRANCE2/2 mice (Fig. 7 D). Despite the increased colo-
nization, the percentage of CD41CD32 cells within the
CD451 population in day 0 MLNs from TRANCE(2/2,Tg)
mice was still significantly lower than that from WT or
TRANCE.TG-1 littermates (Fig. 7 D), and in fact similar
to that observed in day 0 rMLNs from LTa2/2 mice (Figs.
5 C and 7 D). However, transgenic TRANCE expression
restored the cluster formation of CD451CD41CD32 cells
such that most of the CD451CD41CD32 cells were identi-
fied as clusters in discrete regions of day 0 MLNs (Fig. 6).
Moreover, the colocalization of MAdCAM-11 endothelial
venules with clusters of CD41CD32 cells could be ob-
served in day 0 MLNs from TRANCE(2/2,Tg) mice (Fig. 6).
As transgenic expression of TRANCE could partially
rescue the reduced numbers of CD451CD41CD32 cells
and also the lack of LNs in TRANCE2/2 mice, we ad-
dressed whether overexpression of TRANCE in LTa2/2
mice could restore the defects in these mice. However,
generation of neither LNs nor PP formation could be re-
stored by overexpression of TRANCE in LTa2/2 mice
(data not shown).
Similar to TRANCE.TG-1 mice, TRANCE.TG-3
mice, which express transgenic TRANCE only on T cells,
also rescued LN development in TRANCE2/2 mice,
though at different degrees (data not shown). Thus, these
results allow us to make the following conclusion: restricted
restoration of TRANCE expression in TRANCE2/2 mice
was sufficient to support LN genesis and also increased the
relative number of CD41CD32 cells in the CD451 popu-
lation, their cluster formation, and the formation of MAd-
CAM-11 endothelial venules.
Discussion
TRANCE is a member of the TNF family, which has
been shown to play diverse roles in maintaining proper
bone homeostasis and also in regulating the immune system
in adult animals (32). Inactivation of the murine TRANCE
gene revealed its pivotal role during the development of
LNs (this work and reference 17). The role of the
TRANCE/TRANCE-R system during LN organogenesis
parallels that of the LT/LT-bR system, which is also essen-
tial for LN development (6). In contrast, although the
TRANCE/TRANCE-R system is essential for LN devel-
opment, it is dispensable for PP development, which re-
quires the LT/LT-bR system.
Over the past several years, a number of additional gene
products were shown to play critical roles during the de-
velopment of LNs. For example, in addition to the
TRANCE/TRANCE-R or LTab/LT-bR systems, vari-
ous transcription regulators such as Id2 and RelB, signal
transducers TRAF6 and NIK, and a chemokine receptor,
BLR-1, were shown to be important for LN genesis (7–10,
13, 14, 19, 20, 22, 23, 27–29, 33, 34). However, how and
which steps of LN development are regulated by these fac-
tors are not well understood.
Nonetheless, recent experiments have suggested that
colonization of developing LNs or PPs by a4b7
1CD41
CD32 cells might be critical for the subsequent maturation
of these secondary lymphoid organs (27, 33). This hypoth-
esis was based on the observation that developing LNs or
PPs collect the a4b7
1CD41CD32 cells, which express
LTab, RelB, IL-7Ra, IL-2Rgc, and BLR-1, all of which
were shown to be important for the genesis of LNs or PPs
(7, 8, 13, 14, 22, 23, 27–29, 33, 34).
The fate of CD451CD41CD32 cells during the early
development of LNs from various LN-less mutant mice has
not been examined to date. However, some progress has
been made in analyzing those cells in developing PPs. For
example, no CD41CD32IL-7Ra1 cells were detected in
the fetal intestines of Id22/2 mice, which failed to develop
PPs (35). In addition, when developing intestines from IL-
7Ra, Janus kinase 3, or IL-2Rgc knockout mice that lack
PPs were examined, no discrete clusters of CD41CD32
cells were detected (31, 33, 34, 36). The lack of clusters of
CD41CD32 cells in developing intestines was also ob-
served in LTa2/2 mice, which failed to develop PPs (31).
Taken together, these results suggested that the presence of
clusters of a4b7
1CD41CD32 correlates with the develop-
ment of PPs.
In this study, we have examined the fate of a4b7
1
CD41CD32 cells in developing LNs and also examined
how TRANCE or LTab might affect them. We have first
shown that both TRANCE and TRANCE-R are ex-
pressed on a4b7
1CD41CD32 cells within developing LNs.
Although B cells found in early MLNs also express
TRANCE-R, it is most likely that TRANCE regulates the
fate of TRANCE-R1CD41CD32 cells in an autocrine or
paracrine manner, as B cells are not required for LN forma-
tion. In addition, similar to TRANCE, LTab expression is
restricted to a4b7
1CD41CD32 cells, whereas LT-bR is
expressed only on a subpopulation of CD452 cells, indicat-
ing that the initial target cells for TRANCE and LT are
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When rMLNs from newborn TRANCE2/2 mice were
analyzed, there was a significant reduction in the percent-
age of CD451CD41CD32 cells among leukocytes. Thus,
these results indicated that TRANCE indeed regulates
the degree of colonization by CD451CD41CD32 cells
within developing LNs. Although reduced in numbers,
CD451CD41CD32 cells found in day 0 rMLNs from
TRANCE2/2 mice expressed normal levels of a4b7 inte-
grin, which is the ligand for MAdCAM-1, a dominant ad-
dressin found in the high endothelial venules of developing
MLNs. This suggests that in the absence of TRANCE,
CD451CD41CD32 cells can still differentiate from their
precursors. Consistent with this notion, normal coloniza-
tion by CD451CD41CD32 cells was observed in develop-
ing intestines from TRANCE2/2 mice. In addition,
TRANCE2/2 mice have normal development of NK cells,
which can also be found as progeny from CD451
CD41CD32 precursor cells (27). This apparently normal
development of CD41CD32 cells in the fetal intestines
makes the defects of TRANCE2/2 mice distinct from
those of Id22/2 mice, which showed a total lack of
CD41CD32 precursor cells and NK cells (35). Therefore,
it is likely that TRANCE is required for maintenance of
colonization by CD451CD41CD32 cells specifically within
the developing LNs in situ.
The reduction in the number of CD451CD41CD32
cells in developing LNs but not in PPs suggests that distinct
factors other than TRANCE are produced in fetal intestines
to support the continued colonization by CD451CD41
CD32 cells. Conversely, it is possible that the few CD451
CD41CD32 cells found in day 0 rMLNs from TRANCE2/2
mice could be the result of the limited amounts of these in-
testinal factors present in developing LNs.
In addition to the failure of colonization, CD451CD41
CD32 cells found in rMLNs from newborn TRANCE2/2
mice failed to organize into discrete clusters. Similar to
TRANCE2/2 mice, LTa2/2 mice also had defects in colo-
nization and cluster formation by CD451CD41CD32 cells
in day 0 rMLNs. Thus, the cluster formation of CD451
CD41CD32 cells as well as their colonization within devel-
oping LN anlage seems to be critical for proper LN devel-
opment. Indeed, when day 0 MLNs from TRANCE(2/2,Tg)
mice were examined, we showed that the degree of coloni-
zation by CD451CD41CD32 cells, though increased com-
pared with TRANCE2/2 mice, was still low and even com-
parable to that found in LTa2/2 mice. However, in contrast
to LTa2/2 mice, CD451CD41CD32 cells were organized
into discrete clusters in day 0 MLNs of TRANCE(2/2,Tg)
mice.
Taken together, our studies establish that two TNF fam-
ily systems, TRANCE/TRANCE-R and LTab/LT-bR,
regulate the colonization and cluster formation by CD451
CD41CD32 cells within developing LNs, potentially in se-
quential events, and suggest that both events are required
for proper LN development. In addition, we showed that
in the absence of either system, the network of MAdCAM-11
endothelial venules is not fully established, which results in
the arrest of LN development at the stage where LN anlage
needs to be expanded with various leukocytes. Thus, we
speculate that the TRANCE/TRANCE-R or LT/LT-bR
system is required for LN anlage to continue stage III de-
velopment, but not for the initiation of colonization by he-
matolymphoid cells within developing LN anlage, which
begins stage III (see Introduction). Moreover, our results
now suggest that the mode of regulation of LN develop-
ment by CD451CD41CD32 cells appear to parallel that of
PP development, such that these cells also colonize and
form clusters in developing intestines (31).
So how might TRANCE or LTab regulate the fate of
CD451CD41CD32 cells within developing LNs, which in
turn are critical for subsequent LN genesis? In the case of
TRANCE, one can speculate the following scenarios. First,
TRANCE may work as a survival factor for CD451
CD41CD32 cells. This is intriguing, as it was previously
shown that TRANCE enhances the viability of dendritic
cells, for which CD451CD41CD32 cells can be precursor
cells (27, 37). However, transgenic overexpression of Bcl-2
in all CD451 cells failed to restore the LN development in
TRANCE2/2 mice (data not shown), suggesting that a
simple enhancement of the viability of those CD451
CD41CD32 cells by TRANCE might not be the critical
mechanism. Another possibility would be that TRANCE
regulates the activation/differentiation of CD451CD41
CD32 cells within developing LNs in situ. This is a likely
possibility, as TRANCE has been shown to be a differentia-
tion factor during osteoclast development (38, 39), and also
to induce various cytokines and chemokines in dendritic
cells or osteoclasts (our unpublished data). Finally, the
TRANCE/TRANCE-R system might regulate the mi-
gration of CD451CD41CD32 cells into developing LN an-
lage. Although this possibility is consistent with the reduced
number of CD451CD41CD32 cells and the reduced net-
work of MAdCAM-11 endothelial venules observed in day
0 rMLNs from mutant mice, the fact that these cells and
structures exist in the nascent LNs suggests that TRANCE
is not essential for the initiation of migration.
Although the deficiency of TRANCE or LTa arrests
LN development at a similar stage and alters the fate of
CD451CD41CD32 cells similarly in LN anlage, it appears
that the LTab/LT-bR systems regulates LN genesis inde-
pendently of the TRANCE/TRANCE-R system. In sup-
port, we showed in this study that the initial target cells of
TRANCE or LTab ligands are distinct, as TRANCE-R
and LT-bR are expressed on CD451CD41CD32 cells and
CD452 stromal cells, respectively. This also suggests that
the fate of CD451CD41CD32 cells must be regulated in-
directly by LTab. Second, TRANCE-TG.1, which re-
stored LN development in TRANCE2/2 mice, failed to
rescue the defects in LN organogenesis of LTa2/2 mice. In
addition, administration of agonistic anti–LT-bR Ab into
developing TRANCE2/2 embryos failed to restore LN de-
velopment despite normal LT-bR expression in day 0
rMLNs from these mice (data not shown), whereas it did in
LTa2/2 mice as reported previously (13).
However, the similar defects in the fate of CD451
CD41CD32 cells observed within rMLNs from TRANCE-1477 Kim et al.
or LTa-deficient mice suggest that TRANCE/TRANCE-R
and LTab/LT-bR systems must work in a similar fashion.
Considering the fact that the number of CD451CD41CD32
cells found in day 0 rMLNs is always lower in the TRANCE2/2
mice than in LTa2/2, and that LTa2/2 day 0 rMLNs con-
tained a comparable number of CD451CD41CD32 cells
compared with TRANCE(2/2,Tg), which developed LNs, we
postulate the following regulation of LN development by
TRANCE and LTab ligands. The TRANCE/TRANCE-R
system operates at the beginning of stage III when a4b7
1
CD41CD32 cells start migrating into LN anlage and supports
the continued colonization by CD451CD41CD32 cells within
the developing LN anlage. When the number of CD451
CD41CD32 cells reaches a critical point, the interaction
between CD451CD41CD32 cells and stromal cells via the
LTab/LT-bR system leads to the homotypic interaction
of CD451CD41CD32 cells to form compact clusters.
These clusters of CD451CD41CD32 cells provide a com-
munity effect for subsequent differentiation of CD451
CD41CD32 cells themselves and other surrounding cells
(i.e., MAdCAM-11 endothelial cells) within developing
LN anlage. Such a model is similar to the community effect
that has been described for tissue formation arising from a
variety of different types of precursor cells (40).
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